TietoEnator has received Frost & Sullivan’s award for continuously innovating and upgrading individual disciplines of laboratory information systems (LIS) technology. The 2008 Frost & Sullivan European Laboratory Information Systems Product Differentiation Innovation Award is presented each year to a company that has best demonstrated the ability to develop and/or advance products with more innovative capabilities than competing vendors and products.

Frost & Sullivan Research Analyst Shriram Shanmugham said: “TietoEnator’s deep understanding of customer requirements, the provision of complete healthcare IT solutions and strategic technology upgrades have enabled the company to capture nearly 47.5 percent of revenues in the Scandinavian LIS market in 2007-2008.TietoEnator clearly understands that in a mature LIS market, it is imperative that existing customers are satisfied and individual LIS disciplines experience technological innovation at regular intervals.”

Arto Ryymin, who is responsible for the healthcare and welfare business in TietoEnator, said: “I want to congratulate all of our people and customers on this recognition. The award proves that we have had the right strategy in supporting improvements to the quality and efficiency of healthcare. It is extremely motivating to create customer benefits for the most important industry in the world.”

As one of the leading European providers in the industry, TietoEnator offers a broad portfolio of outstanding healthcare ICT solutions. It provides LIS management solutions to all disciplines (haematology, microbiology, cytology, etc.) supported by hospital laboratories. Currently TietoEnator is delivering an upgrade to genetic health control, a new lab discipline. This is a specific diagnostic tool used in a hospital laboratory to screen symptoms of cancer. It is aimed particularly at monitoring women’s health in Scandinavia.